The aim of this event was to ensure the successful launch of EYLEA 8mg, ensure harmonized brand communication and raise internal and external excitement. https://www.bayer.com/en/poap-tc

In January 2024, EYLEA 8mg achieved new heights in Bayer’s mission of 'helping patients see a better life'. You celebrated this major milestone in the EYLEA journey by attending the EYLEA 8mg Global Townhall on January 16, 2024. Either in person in Basel or virtually worldwide. You met the hosts Jan Voss and Zoran Hasanbasic (EYLEA IPT Leads) and the full cross-functional team and learned what they achieved to bring EYLEA 8mg to market, also what the real benefit means to patients and their caregivers. Anne-Grethe Mortensen, Mike Devoy and Stefan Oelrich brought their perspectives and spoke about what this success-story meant to the Pharma division and to the company as a whole. https://www.bayer.com/poap

Thank you for celebrating with us by minting the “Choose to be a hero” POAP. Bayer Hellas is organizing a special day to raise awareness on the easy and painless process of bone marrow donating. Becoming a bone marrow donor is an act of profound generosity. A selfless act that can make a difference and give a patient a second chance at life and hope for the future! Learn more here: https://chooselifeworld.com/ This is the first POAP ever given in a BeWell@Bayer activity for our employees. If you were at the event and received this POAP, you are a True Hero. Terms & Conditions: https://www.bayer.com/en/poap-tc

Moving to our new office, is a change for all of us. Agile collaboration and F2F interaction is the key value now and this new work environment supports this. We welcome you all to our new vibrant community where we feel nurtured, with a sense of belonging. Focus rooms, phone booths, meeting rooms & collaboration corners, are available now for you. Create your ideal hybrid work schedule and be part of the community. Let’s create, collaborate & celebrate! Bayer terms & conditions: https://www.bayer.com/en/poap-tc

With the aim of protecting more and more Greek patients, a new product in Cardiovascular Medicine is launched. KERENDIA is now available for patients with CKD & Type 2 Diabetes. Welcome to Bayer Hellas internal Kerendia launch event, focusing on educating & preparing the Sales Team for a successful product promotion in the Greek market. In this event, you familiarized yourselves with the promotional materials & the role plays. This is the first POAP related to a pharmaceutical product. If you received this POAP, you are a True Pioneer in the Web3 space. Bayer is proudly promoting innovative practices. https://www.bayer.com/en/poap-tc